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We investigated  which  variables  possibly  inﬂuence  the  amount  of  foot-and-mouth  disease
virus  (FMDV)  shed  in  secretions  and  excretions  by FMDV  infected  animals,  as  it is  likely  that
the amount  of FMDV  shed  is  related  to  transmission  risk.  First,  in  a separate  analysis  of  lab-
oratory data,  we  showed  that the  total  amount  of  FMDV  in secretions  and  excretions  from
infected animals  is  highly  correlated  with  maximum  titres  of FMDV.  Next,  we collected  data
from 32  published  scientiﬁc  articles  in  which  FMDV  infection  experiments  were  described.
The  maximum  titres  of  FMDV  reported  in different  secretions  and  excretions  (the response
variable)  and  the  experimental  conditions  in which  they  occurred  (the  explanatory  vari-uantiﬁcation
xcretion
ables),  were  recorded  in a database  and  analyzed  using  multivariate  regression  models  with
and without  random  effects.  In both  types  of  models,  maximum  titres  of  FMDV  were  signif-
icantly (p <  0.05)  associated  with  types  of secretions  and  excretions,  animal  species,  stage
of the  disease  and days  post  infection.  These  results  can  be used  to  prioritize  biosecurity
gency  
he Autmeasures  in  contin
© 2013 T
. Introduction
Foot-and-mouth disease (FMD) is a contagious viral dis-
ase  of cloven-hoofed animals, both domestic (cattle, pigs,
heep,  goats and domestic buffalo) and wild (Thomson,
994). The FMD  virus (FMDV) can be transmitted by several
outes  (Sellers, 1971; Hyslop, 1970), with direct contact
etween animals considered the most important. The virus
an  also be transmitted by several indirect routes. In the
uropean Union, an outbreak of FMD  invokes an oblig-
tory  stand-still of animal transport (OIE, 2012). During
uch  a stand-still, direct contact between infected animals
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in one farm and non-infected animals in another farm is
theoretically impossible, leaving indirect transmission via
contaminated material the most likely remaining route of
transmission. In this respect, airborne transmission has
been  also considered (Henderson, 1969).
During epidemics, even when there is a complete stand-
still  of animal transport, transmission between farms has
been  shown (Bouma et al., 2003). That indirect routes play a
role  in such transmission is clear from the observation that
veterinarians were involved in the transmission of FMDV
in  outbreaks both in Denmark in 1982, and in Italy in 1993,
either  by using contaminated surgical equipment or by vis-
iting  farms after visiting an infected farm. Similarly, during
the  2001 FMD  outbreak in the United Kingdom, it was sug-
gested  that farmers were involved in the transmission of
the  virus between sheep ﬂocks (Kitching, 2005). In the 2001
United  Kingdom outbreak, the basic reproduction number
Open access under CC BY-NC-ND license.remained above 1, that is, FMDV transmission continued
despite the standstill in animal transport (Woolhouse et al.,
2001).  Thus indirect transmission of FMDV can have enor-
mous  consequences.
-NC-ND license.
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It can be assumed that the risk of indirect transmis-
sion of FMDV is related to the total amount of FMDV
present in the environment through contamination by
secretions and excretions from FMDV infected animals.
Here, secretions include material released from glands
(e.g.  milk, semen, saliva) whereas excretions refer to any
other  products released from animals (e.g. faeces, material
released from the respiratory tract, urine, probang samples,
nasal  discharge and blood). The concentrations of FMDV
in  infected secretions and excretions have been reviewed
(Pharo, 2002). However we analyzed the quantitative rela-
tionship  between possible explanatory variables and the
amount  of FMDV in infected secretions and excretions.
2. Materials and methods
2.1.  Materials
2.1.1. Laboratory data
Laboratory  reports from animal studies performed at
the  Central Veterinary Institute (The Netherlands) were
mined for all available daily data on virus secretion in milk
from  cattle (Orsel et al., 2007a) and on virus secretion and
excretion in oropharyngeal ﬂuid (OPF) swabs from cattle
(Orsel  et al., 2005), sheep (Eblé et al., 2008; Orsel et al.,
2007b) and pigs (Eblé et al., 2004, 2006a,b, 2007; Orsel
et  al., 2007c). These data were used to identify the response
variable for our multivariate regression analysis.
2.1.2. Literature data
Data  on FMDV in secretions and excretions were
collected from 32 scientiﬁc articles published between
1965 and 2007 (see Annex) found in internal databases
and through the electronic (external) databases Scopus1
and PubMed2 in 2010, all reporting experimental trials
involving FMDV infection. The electronic databases were
explored using the keywords: foot-and-mouth disease,
virus, infection and excretion. References cited in retrieved
articles were reviewed to identify additional ones. The arti-
cles  had to meet two basic criteria for their inclusion in the
analysis:  be written either in English, Spanish or French,
and  contain data on animal experiments with FMDV. They
needed  to contain information on the maximum titre(s)
of  FMDV detected in secretions and/or excretions, and
additional information on one or more of the following:
the type(s) of secretion or excretion in which the virus
was  detected, route of infection, animal species, FMDV
serotype, stage of disease (clinical and non-clinical), dose
of  infection and/or days post infection at which the maxi-
mum  secretion or excretion occurred. Missing data on one
or  more of these variables were recorded as not available
(N.A.). These data were used as the response and possi-
ble  explanatory variables for our multivariate regression
analysis.Per individual animal, the maximum titre of FMDV
(including the experimental conditions) was recorded.
Virus titres were reported as 10log TCID50/ml. Plaque
1 http://www.scopus.com/.
2 http://www.ncbi.nlm.nih.gov/pubmed/.nary Medicine 113 (2014) 23– 33
forming units (PFU) were converted to TCID50 (Horzinek,
1985). Median doses, such as 50% cattle infection dose
(CID50), 50% mouse infection dose (MID50) or 50% mouse
lethal dose (MID50) per ml,  were considered equal to
50%  tissue culture infective dose (TCID50/ml) (House and
Yedloutschnig, 1982). The maximum recorded titre was
the  maximum titre over time for an individual animal.
If  the maximum titre was reported per group of ani-
mals, this resulted in one observation (from blood in
Alexandersen et al. (2003); from airborne excretion in
Alexandersen et al. (2002), Alexandersen and Donaldson
(2002), Donaldson et al. (1970, 1981, 1982), Gloster et al.
(2007),  and Sellers and Parker (1969); from probang, milk,
faeces  and blood in Burrows (1968); from milk in Burrows
(1971); and, from probang and nasal discharge in Burrows
(1972)). Data on airborne excretion were recorded as 10log
TCID50/animal/day.
The  recorded secretion or excretion types were air-
borne, faeces, milk, probang, semen, urine, blood, nasal
discharge, oropharyngeal ﬂuid (OPF) swabs, and saliva. The
category  faeces contains data on material collected from
the  rectum (Burrows et al., 1968) and from rectal swabs
(Garland, 1974). Probang refers to oropharyngeal samples
that  were obtained after scraping the oropharynx with a
sampling  cup.
Routes  of infection were recorded as: contact (if an
infected donor and a susceptible contact animal shared a
common  experimental unit); intranasal (IN, if the animals
were  infected via the intranasal route) or parenteral (if the
animals  were infected intravenously (IV), intramuscularly
(IM), intralingually, intracutaneously (IC), intramammary
or intradermally (ID)).
Animal  species were recorded as cattle (bull, steer, ox,
cow,  calf and heifer), swine (pigs) or small ruminants
(sheep, lambs and goats). The FMD  viruses used for infec-
tion  were recorded based on FMDV serotype, i.e. A, O, C,
Asia  1, SAT 1, SAT 2, SAT 3, but no subdivision was  made
to  the level of subtypes. The stage of disease was recorded
as  ‘clinical’ when lesions or clinical signs (including fever)
were  reported; otherwise it was  recorded as ‘non-clinical’.
Dose of infection (ranging from 0.95 to 10.15 TCID50/ml)
was  recorded. Days post infection was recorded as the day
when  the maximum titres in the secretion or excretion
were observed (ranging from 0.33 to 28 dpi).
2.2.  Methods
2.2.1. Identifying the response variable for the
multivariate regression analysis
A proxy for the total amount of FMDV secreted and
excreted by the infected animals was  established using
available laboratory data from OPF swab samples and
milk  samples. The total amount of secreted and excreted
FMDV (per individual animal) was  calculated by summing
the  observed viral amounts (without logarithmic trans-
formation) from consecutive observations (area under the
curve,  AUC). In a univariate regression analysis, the log-
arithm  of the AUC (10log AUC) was  used as the response
variable. Three explanatory variables were analyzed: (1)
the  maximum virus titre (max 10log TCID50/ml), (2) the
time when the maximum virus titre occurred (10log
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Table 1A
Descriptive statistics on data retrieved from the literature on maximum virus excretion from cattle.
FMDV infection variables Number of observations Maximum titre
average  (range)
TCID50/ml*
Maximum titre
standard  deviation
TCID50/ml*
Total 220 4.51 (0.95,8.65) 1.66
Type  of secretion and excretion
Airborne  9 4.33 (3.88, 5.08) 0.36
Blood  47 4.03 (0.95,6.20) 1.18
Faeces  5 1.55 (1.50, 1.75) 0.10
Milk  40 4.48 (2.15, 7.35) 1.46
URT  (OPF swabs, saliva and nasal discharge) 33 5.70 (1.25, 8.50) 1.66
Nasal  discharge only 7 6.09 (2.75, 7.85) 1.61
Probang  68 4.91 (2.20, 8.65) 1.53
Semen  8 4.55 (2.10, 6.20) 1.33
Urine  10 1.93 (1.00, 3.80) 0.87
Route  of infection
Intranasal 37 4.68 (0.95, 8.65) 1.76
Parenteral  95 4.75 (1.25, 8.50) 1.63
Contact  88 4.17 (1.00, 8.05) 1.57
Undetermined  1 4.60 (NA) NA
FMDV  serotype
A  38 3.98 (2.10, 8.05) 1.40
O  140 4.54 (0.95, 8.65) 1.68
Asia-1  4 4.10 (2.80, 5.00) 0.80
C  6 4.6 (2.10, 7.00) 1.80
SAT  (1, 2, 3) 12 4.26 (2.10, 6.00) 1.06
Undetermined  20 5.52 (1.25, 8.15) 1.81
Stage  of disease
Non-clinical 61 4.52 (0.95, 8.65) 1.66
Clinical  123 4.62 (1.00, 8.50) 1.72
Undetermined  36 4.11 (1.15, 7.15) 1.36
Dose  of infection (below/above median: 5.5 TCID50/ml)
0.95–5.4 TCID50/ml  51 4.94 (0.95, 8.65) 1.71
5.5–10.15  TCID50/ml 59  4.30 (2.10, 7.20) 1.48
Undetermined  110 4.43 (1.00, 8.15) 1.69
Days  post infection (dpi; below/above median: 3 dpi)
0.3–2.8 dpi 65 4.82 (1.00, 8.50) 1.69
3–28  dpi 115 4.07 (0.95, 8.65) 1.49
Undetermined  40 5.28 (1.25, 8.15) 1.67
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* TCID50 per animal per day for airborne excretion; dose of infection and
itre  calculated using the maximum titres when either the dose of infecti
ays post infection) and, (3) their product 10log (max
CID50/ml  × days post infection) which is equal to max
0log TCID50/ml  + 10log days post infection. For each uni-
ariate model, the r2 values were calculated. An F-test (in
NOVA) was used to test the signiﬁcance of each variable.
he  best explanatory variable was used as response vari-
ble  in the multivariate regression analysis.
.2.2. Identifying the explanatory variables for the
ultivariate regression analysis
A dataset was built using the information found in the
iterature. Descriptive statistics of the data can be found in
ables  1A–1C.
Per  individual animal, several categorical variables were
ecorded: type of secretion and excretion, route of infec-
ion,  animal species, FMDV serotype and stage of disease
nd,  two continuous variables: dose of infection and days
ost  infection (Table 2). Categories in which a limited num-
er  of observations were present were combined with
nother category where this made biological sense (e.g.
RT  secretions and excretions, FMDV serotype SAT) (Dohoo
t  al., 2009).st infection were divided as above and below the median of the maximum
e days post infection were available.
2.2.3.  Multivariate regression analysis
Under the assumption that all the included FMDV infec-
tion  experiments share a common true effect size, we used
a  model in which we  did not adjust for variability between
data  sources (a linear model without random effects).
Under the assumption that some of the FMDV infection
experiments from the different data sources differ from
each  other in ways that could impact on the effect in the
model, we used a model in which we adjusted for variabil-
ity  between the data sources (a linear model with random
effects). Three different random effects were evaluated:
“article” (articles included in the analysis, see Annex), “lab-
oratory”  (laboratories where the original analyses had been
performed) and their nested effect. All random effects
were assumed to follow a Gaussian distribution (Ott and
Longnecker, 2010). The models were compared by com-
puting the AIC (Table 3).
Due to the small number of identiﬁed explanatory
variables (Table 2), we  used them all in the multivariate
regression analysis of the models with and without ran-
dom  effects. To select the variables that best explained
total FMDV secreted and excreted by infected ani-
mals, a stepwise regression procedure with bidirectional
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Table 1B
Descriptive statistics on maximum virus excretion from swine.
FMDV infection variables Number of
observations
Maximum  titre
average  (range)
TCID50/ml*
Maximum titre
standard  deviation
TCID50/ml*
Total 71 5.15 (3.41, 8.60) 0.98
Type  of secretion and excretion
Airborne  22 6.00 (4.48, 8.60) 0.89
Blood 6 5.18 (3.90, 6.50) 1.07
OPF  (swabs and saliva) 43 4.70 (3.41, 6.45) 0.66
Route  of infection
Parenteral 39 5.44 (3.85, 8.08) 0.84
Contact  32 4.78 (3.41, 8.60) 1.01
FMDV  serotype
A  5 5.65 (4.48, 6.68) 0.70
O  64 5.01 (3.41, 6.54) 0.81
C  2 8.34 (8.08, 8.60) 0.26
Stage  of disease
Non-clinical 5 5.80 (5.30, 6.54) 0.50
Clinical  43 5.09 (3.41, 8.60) 1.04
Undetermined  23 5.11 (3.85, 8.08) 0.89
Dose  of infection (below/above median: 5.5 TCID50/ml)
0.95–5.4 TCID50/ml 19 4.94 (3.85, 6.50) 0.62
5.5–10.15 TCID50/ml  18 6.01 (4.48, 8.10) 0.72
Undetermined  34 4.81 (3.41, 8.60) 0.99
Days  post infection (dpi; below/above median: 3 dpi)
0.3–2.8 dpi 22 5.59 (4.35, 8.60) 0.97
3–28  dpi 41 4.76 (3.41, 6.45) 0.77
Undetermined  8 5.95 (5.10, 8.10) 0.93
Total refers to all the maximum titres observations that were encountered.
* TCID50 per animal per day for airborne excretion; dose of infection and days post infection were divided as above and below the median of the maximum
titre  calculated using the maximum titres when either the dose of infection or the days post infection were available.
Table 1C
Descriptive statistics on maximum virus excretion from small ruminants (sheep and goats).
FMDV infection variables Number of
observations average
(range)
Maximum  titre
standard  deviation
TCID50/ml*
Maximum titre
TCID50/ml*
Total 36 3.93 (0.86, 6.28) 1.25
Type  of secretion and excretion
Airborne  12 3.75 (2.38, 5.08) 1.00
Blood  8 3.34 (1.50, 5.20) 1.13
OPF  (swabs and saliva) 16 4.37 (0.86, 6.28) 1.31
Route  of infection
Intranasal 11 4.69 (3.26, 6.28) 0.83
Parenteral  18 3.51 (1.50, 5.20) 1.10
Contact  6 3.70 (0.86, 5.45) 1.64
Undetermined  1 4.60 (NA) NA
FMDV  serotype
A  2 2.53 (2.48, 2.58) 0.05
O  23 4.35 (0.86, 6.30) 1.12
C  3 3.28 (2.38, 5.08) 1.27
Undetermined  8 3.34 (1.50, 5.20) 1.13
Stage  of disease
Non-clinical 8 3.69 (0.86, 5.08) 1.37
Clinical  13 4.81 (3.26, 6.28) 0.79
Undetermined  15 3.30 (1.50, 5.20) 1.06
Dose  of infection (below/above median: 5.5 TCID50/ml)
0.95–5.4 TCID50/ml  12 4.69 (3.26, 6.28) 0.79
5.5–10.15  TCID50/ml 7  3.33 (2.38, 5.08) 1.05
Undetermined  17 3.65 (0.86, 5.45) 1.33
Days  post infection (dpi; below/above median: 3 dpi)
0.3–2.8 dpi 20 3.74 (1.50, 5.26) 1.18
3–28  dpi 14 4.17 (0.86, 6.28) 1.34
Undetermined  2 4.23 (3.48, 4.98) 0.75
Total refers to all the maximum titres observations that were encountered.
* TCID50 per animal per day for airborne excretion; dose of infection and days post infection were divided as above and below the median of the maximum
titre  calculated using the maximum titres when either the dose of infection or the days post infection were available.
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Table 2
Explanatory variables for the multivariate regression analysis.
Variable Type Categories/speciﬁcations
Type of secretion and excretion Categorical Airborne, blood, faeces, milk, URT (OPF swabs, saliva, nasal discharge),
probang,  semen, urine
Route  of infection Categorical Intranasal, contact, parenteral (intravenous, intramuscular, intralingual,
intracutaneous, intramammary or intradermal)
Animal species Categorical Cattle, swine, small ruminants (sheep and goats)
FMDV serotype Categorical A, Asia-1, C, O, SAT
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Dose  of infection Continuous 
Days  post infection (dpi) Continuous 
limination (Faraway, 2002) was used in multivariate
egression analyses. No interaction terms were included in
he  initial (full) models (Table 3). The selection of explana-
ory  variables (or ﬁxed effects) was carried out using 2
riteria:  the signiﬁcance level (p < 0.05) and the Akaike
nformation Criterion (AIC). The variable with the high-
st  p-value was removed from the models. In addition,
henever deletion of a variable occurred, we checked
or confounding. If the deletion of a variable resulted in
 change of more than 25% in the regression estimates,
his indicated confounding (Hosmer and Lemeshow, 1989;
oordhuizen et al., 2001). Confounding variables were
etained in the models. After deletion of those variables
ith p-values higher than 0.05, we tested whether their
nclusion was signiﬁcant (p < 0.05) and whether the inclu-
ion  led to signiﬁcant reduction in AIC (AIC > 2, Burnham
nd  Anderson, 2004). After selecting the explanatory vari-
bles  of the models, one level interaction terms were
ncluded one by one in the models. When the interaction
erm allowed improvement of ﬁt (p < 0.05), it remained in
he  models.
Both ﬁnal models (Table 3) were checked for
omoscedasticity, normality and outliers by residual
nalysis. Outliers were retained as they were thought to
eﬂect  relevant deviations in this sort of data. In order
o  test whether an outlier affected the estimates or the
able 3
omparison of ﬁtted models for the max 10log TCID50/ml  based on published dat
ions  = 204).
Explanatory variables Interact
Model without random effects
Null model – – 
Full  model Type of secretion and excretion, dpi,
animal species, route of infection, FMDV
serotype, stage of disease
– 
Final model Type of secretion and excretion, dpi, animal
species, FMDV serotype, stage of disease
Type  of 
excretio
secretio
disease,
excretio
serotype
Model with random effects
Null  model – – 
Full  model Type of secretion and excretion, dpi,
animal species, route of infection, FMDV
serotype, stage of disease
– 
Final model Type of secretion and excretion, dpi,
animal species, stage of disease
N.A. ical, clinical
5 to 10.15 TCID50/ml
y 0.33 to 28 post infection
p-values, an outlier was excluded from the data and the
models were re-ﬁt. When the outlier had no inﬂuence on
the  estimates or p-values, it remained in the models.
All statistical analyses were performed using the R soft-
ware  version 2.11.0 with its standard add-on packages stats
and  lme4 (R Development Core Team, 2012).
3. Results
3.1. Identifying the response variable for the multivariate
regression analysis
The  univariate regression analysis between 10log AUC
and  max 10log TCID50/ml  gave a correlation coefﬁcient (r2)
of  0.98 for OPF swab samples and of 0.99 for milk samples
(p-value <0.001). The analysis between 10log AUC and 10log
days  post infection gave correlation coefﬁcients of 0.01 for
OPF  swab samples and 0.09 for milk samples. There was no
signiﬁcant  association between 10log AUC and 10log days
post  infection (OPF swab samples, p-value 0.3; milk sam-
ples,  p-value 0.2). The addition of 10log days post infection
in  the model with max 10log TCID50/ml  did not improve the
ﬁt  of the model neither for OPF swab samples nor for milk
samples (p-value 0.3 and 0.4 respectively). The variable
max 10log TCID50/ml  was  therefore used as the response
variable in the multivariate regression analysis.
a of FMDV infection studies using the same dataset (number of observa-
ion terms Random effects AIC
– 759.5
– 642.6
secretion and
n*animal species, type of
n and excretion*stage of
 type of secretion and
n*FMDV serotype, FMDV
*stage of disease
– 584.6
Article 727.4
Laboratory  763.2
Articles  in laboratories 728.5
Article 622.7
Article 615.4
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Fig. 1. Boxplot of FMDV amounts (10log TCID50/ml) in secretions and
excretions from cattle (in dark blue), swine (in dark red) and small rumi-
nants (in dark green). In airborne excretion (*), 10log TCID50/animal/day
is reported. URT, upper respiratory tract secretions and excretions. When
applicable, each column contains the extreme of the lower whisker, the
lower hinge, the median, the upper hinge and the extreme of the upper
whisker for one plot. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web  version of this article.)
3.2. Literature data
The  references of the 32 used scientiﬁc articles on FMDV
infection experiments are shown in the Annex. The FMDV
infection experiments reported in the selected scientiﬁc
articles were carried out in 5 FMD  reference laboratories:
the Pirbright Institute (IAH, Pirbright, United Kingdom), the
Plum  Island Animal Disease Center (PIADC, Orient Point,
New  York, United States of America), the Central Veterinary
Institute (CVI, Lelystad, The Netherlands), the Pan Amer-
ican  Center for Foot-and-Mouth Disease (PanAftosa, Rio
de  Janeiro, Brazil) and the French Institute for Foot-and-
Mouth Disease (Lyon, France).
In total 327 observations (220 cattle, 71 swine and
36  small ruminants) were retrieved. The data retrieved
from the reviewed scientiﬁc articles are summarized in
Table  1A for cattle, Table 1B for swine and Table 1C for
small  ruminants. All the observed maximum titres of FMDV
in  the different types of secretions and excretions per ani-
mal  species were used to calculate the median maximum
amounts and are shown in Fig. 1. The highest FMDV median
amounts (10log TCID50/ml  or 10log TCID50/animal/day)
were found in URT secretions and excretions from cattle
(OPF  swabs, saliva and nasal discharge samples) followed
by  airborne excretion from swine, probang samples from
cattle  and blood from swine.
3.3. Identifying the explanatory variables for the
multivariate regression analysisCandidate explanatory variables for the multivariate
regression analysis are shown in Table 2. Given that (1)
OPF  swabs and saliva are derived from the oral cavity, andnary Medicine 113 (2014) 23– 33
(2)  there were limited observations in the category nasal
discharge (only available for cattle), we  combined OPF
swabs  with saliva and with nasal discharge and called this
upper  respiratory tract secretions and excretions (URT). In
Table  1A for cattle, we show both URT and nasal discharge
separately to show that the ranges of the maximum titres
of  both are similar. Due to limited observations in the cate-
gories  SAT 1, SAT 2 and SAT 3 from the categorical variable
FMDV serotype, we  also combined the categories SAT 1,
SAT  2 and SAT 3 into the category SAT.
3.4. The ﬁnal model
In  total, data of 327 observations were used to identify
which variables are associated to the amount of FMDV that
is  secreted and excreted by the infected animals. During
the  analysis, ﬁrst we looked at the inclusion/exclusion of
dose  of infection because it had the highest p-value and
because it’s high number of missing data points (161). As
the  comparison of models can only be done between mod-
els  with the same number of observations, we looked at the
effect  of dose of infection separately. Comparison of the full
models  (with 118 observations) with and without dose of
infection  for the data set where dose of infection was  not
missing  revealed that the models without dose of infection
had  a lower AIC than the models with dose of infection.
Therefore dose of infection was excluded from both full
models. Subsequently, all the other variables were looked
at  (Table 3).
The  ﬁnal model without random effects is shown in
Table  4. This model was ﬁtted using 204 observations.
Using the variables selection criteria (p-values and AIC),
4  explanatory variables were identiﬁed to be signiﬁcantly
associated with the total amount of FMDV secreted and
excreted by infected animals: type of secretion and excre-
tion,  days post infection, stage of disease and FMDV
serotype. Even though animal species had a p-value of
0.056,  its inclusion improved the ﬁt of the model (the
AIC  decreased), and its biological relevant. So, in total we
identiﬁed 5 explanatory variables associated with the total
amount  of FMDV secreted and excreted by infected ani-
mals.  No confounding factors were found. The explanatory
variable route of infection dropped out during the step-
wise  regression procedure. In total 4 interactions terms
were  signiﬁcantly associated with the total amount of
FMDV  secreted and excreted by infected animals: “type
of  secretion and excretion with animal species”, “type of
secretion  and excretion with stage of disease”, “type of
secretion and excretion with FMDV serotype” and “FMDV
serotype with stage of disease”. Note that in Table 4 sev-
eral  combinations of categories could not be included in
the  interaction analysis because certain combinations of
categories  were not present in the used scientiﬁc arti-
cles  (e.g. no information on amounts of FMDV in milk
from swine could be retrieved from the scientiﬁc arti-
cles).
Airborne excretion, 0 dpi, cattle, clinical stage of disease
and  FMDV serotype A were chosen as reference categories.
Compared to these reference categories, FMDV is found in
higher  quantities in probang samples (2.5 10log TCID50/ml
higher,  p-value <0.001) and in lower quantities in
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Table 4
Results of the ﬁnal multivariate regression model. Reference categories: airborne, 0 dpi, cattle, clinical, A.
Variable Category Estimate Std. error t-value p-value
Intercept – 4.21 0.45 9.42 <2e −16
Explanatory variables
Type  of secretion and excretion Blood 0.34 0.66 0.51 0.61
Faeces  −2.29 0.72 −3.19 0.001
Milk −0.24 0.53 −0.45 0.65
Urt  1.06 1.39 0.77 0.44
Probang  2.50 0.73 3.43 <0.001
Semen  −0.97 1.03 −0.94 0.35
Urine  −1.90 1.03 −1.85 0.07
Days post infection – −0.07 0.02 −3.42 <0.001
Animal species Small ruminants −1.08 0.39 −2.77 0.01
Swine  −1.58 0.34 −4.60 <0.001
Stage of disease Non-clinical −1.74 1.46 −1.19 0.24
FMDV serotype Asia-1 0.70 1.31 0.53 0.59
C  1.11 0.65  1.71 0.09
O  −0.02 0.47 −0.05 0.96
SAT  0.81 1.14 0.72 0.47
Interactions
Type of secretion and excretion/animal species Airborne: small ruminants 1.08 1.11 0.97 0.33
Airborne:  swine 3.62 0.58 6.26 <0.001
Blood:  swine 2.30 0.57 4.03 <0.001
Type of secretion and excretion/stage of disease Blood: non-clinical −0.97 1.37 −0.71 0.48
Faeces:  non-clinical −0.70 1.70 −0.41 0.68
Milk:  non-clinical 1.83 1.63 1.12 0.26
URT:  non-clinical −2.51 1.42 −1.77 0.08
Probang:  non-clinical −0.64 1.35 −0.47 0.64
Type of secretion and excretion/FMDV serotype Blood: Asia-1 −0.88 1.68 −0.52 0.60
Semen:  Asia-1 1.27 1.86 0.68 0.49
Blood:  C −2.45 1.24 −1.98 0.05
URT:  C 0.58 1.61 0.36 0.72
Semen:  C −2.11 1.47 −1.44 0.15
Blood:  O 0.12 0.71 0.17  0.86
URT:  O 1.00 1.42 0.71 0.48
Probang:  O −0.46 0.77 −0.60 0.55
Semen:  O 2.81 1.17 2.40 0.02
Urine:  O −0.55 1.11 −0.49 0.62
Blood:  SAT −0.91 1.40 −0.65 0.52
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aeces samples (2.3 10log TCID50/ml  lower, p-value 0.001).
he  quantity of secreted and excreted FMDV was high
f  the peak occurred soon after infection and decreased
ith time (0.07 10log TCID50/ml  decrease in time, p-value
0.001). The quantity of virus shed into the environment
as also determined by animal species (e.g. cattle secrete
nd  excrete FMDV in overall higher amounts than other
nimal species). Larger quantities of FMDV were associated
ith  the presence of clinical signs. They were also associ-
ted  with the FMDV serotype that initiated the infection
Table 4).
Based  on the analysis of the interaction terms, the max-
mum  amount of virus found in different secretions and
xcretions depends on the affected animal species, so a
peciﬁc  type of secretion or excretion from a particular
nimal species would have higher levels of FMDV than
hose  from another animal species (e.g. airborne excretion
rom swine contain higher amounts of FMDV than airborne
xcretion from other species). For all secretions and excre-
ions,  except milk, the amount of FMDV was lower during
he  non-clinical stage than during the clinical stage. For
ilk  it was about equal in the non-clinical and clinical
tages.0.35 1.61 0.22 0.83
1.57 1.60 0.98 0.330
2.18 0.65 3.35 0.001
The  interaction term between type of secretion and
excretion and FMDV serotype indicates that infection with
some  FMDV serotypes is associated with presence of more
FMDV  in a speciﬁc secretion or excretion. The interac-
tion term between FMDV serotype and stage of disease
indicates that during infection with a particular FMDV
serotype, variations in the total amounts of secreted and
excreted FMDV are seen during the non-clinical and clin-
ical  stages. The AIC of the ﬁnal model without random
effects was 584.6, the lowest AIC of the examined models
(Table 3).
The  ﬁnal model with random effects is shown in Table 5.
This  model was  ﬁtted using 204 observations. Inclusion of
the  random effect “article” improved the ﬁt of the model.
In  the model with random effects, 4 ﬁxed effects (explana-
tory  variables) were identiﬁed to be signiﬁcantly associated
with  the total amount of FMDV released by the infected
animals: type of secretion and excretion, animal species,
stage of disease and days post infection. No confound-
ing factors were found. The explanatory variables route
of  infection and FMDV serotype dropped out during the
stepwise regression procedure. Because most of the pos-
sible  interactions have to be estimated from comparisons
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Table 5
Results of the ﬁnal multivariate regression model with “article” as random effect. Reference categories: airborne, cattle, clinical, 0 dpi.
Variable Category Estimate Std. error t-value p-value
Intercept – 4.94 0.58 8.57 <2e −16
Explanatory variables
Type  of secretion and excretion Blood −0.76 0.63 −1.21 0.23
Faeces −3.55 0.79 −4.47 <0.001
Milk −1.11 0.71 −1.58 0.12
URT 0.15 0.66 0.23 0.82
Probang 1.05 0.64 1.64 0.10
Semen −0.91 0.73 −1.25 0.21
Urine −3.34 0.69 −4.84 <0.001
Animal species Small ruminants 0.25 0.60 0.42 0.67
Swine 1.33 0.43 3.13 0.002
−0
−0Stage of disease Non-clinical 
Days post infection –  
between articles, we were only able to analyze the interac-
tion  terms in the model without random effects.
Airborne excretion, cattle, clinical stage of disease and
0  dpi were chosen as reference categories. Compared to
these  reference categories, FMDV is found in lower quan-
tities  in faeces samples (3.5 10log TCID50/ml  lower, p-value
<0.001) and in urine (3.3 10log TCID50/ml  lower, p-value
<0.001). The amounts of FMDV secreted and excreted into
the  environment are also determined by animal species
(e.g.  swine excrete higher amounts of FMDV by the airborne
route  than cattle, p-value = 0.002). It is also associated
with the presence of clinical signs (i.e. in the non-clinical
stage of the disease, animals secrete and excrete 0.72 10log
TCID50/ml less virus, p-value = 0.001). Further, the amounts
of  secreted and excreted FMDV are high when they occur
early  after infection and decrease when the peak occurs
later  in time. The AIC of the ﬁnal model with random effects
was  615.4 (Table 3).
Normality  and homoscedasticity were violated neither
in  the model without random effects nor in the model with
random  effects, according to the residual analysis. One out-
lier  (i.e. 8.1 10log TCID50/ml  from a probang sample from
cattle; Burrows et al., 1981) was identiﬁed. The outlier was
retained;  excluding it from the analysis had no inﬂuence
on  the estimates or p-values.
4.  Discussion
The aim of this study was to determine which vari-
ables inﬂuence the total amount of FMDV that is secreted
and  excreted by infected animals (expressed as the 10log
AUC).  This study was performed because we assume that
the  risk of indirect transmission of FMDV is related to the
total  amount of FMDV present in the environment through
contamination by secretions and excretions from FMDV
infected animals.
The  maximum titre of FMDV (max 10log TCID50/ml
or, in the case of airborne excretion, max 10log
TCID50/animal/day) showed a strong relation with the
total  amount of virus that is shed to the environment,
expressed as the logarithm of the sum of consecutive daily
observations on viral amounts (10log AUC). The maximum
titres can therefore be used as a proxy for the total amount
of  virus in excretions and secretions. FMDV maximum
titres are reported in literature differently accordingly.72 0.21 −3.33 0.001
.03 0.03 −1.26 0.21
to the type of secretion or excretion; FMDV titres from
airborne excretions are reported in 10log TCID50 per
animal per day whereas FMDV titres from other types
of  the secretions and excretions are reported per 1 ml of
sample  (10log TCID50 per ml). In our study, the maximum
titres, regardless of denominator (i.e. 10log TCID50/ml  and
10log TCID50/animal/day) were treated similarly. However,
during the interpretation of the results, the difference
between denominators and the difference between the
produced amounts of secretions and excretions have to be
taken  into account (note that infected cows can produce
several litres of contaminated milk per day).
The method used in this study allowed estimation of
the  effect of variables on our variable of interest: the max-
imum  virus titre. One of the advantages of this method is
its  ability to bring together lots of information from numer-
ous  studies on animal experiments with FMDV without the
need  to perform new animal experiments. During the anal-
ysis  of the model with random effects, we  found that the
random effect “article”, possibly more accurately named
“speciﬁc experimental conditions”, inﬂuences the outcome
of  the model. We  therefore report two models, a model
without random effects and a model with “article” as a ran-
dom  effect. Both models identiﬁed the same explanatory
variables except for FMDV serotype, but the latter could
be  explained due to the high correlation between FMDV
serotype and the source of the data (i.e. FMDV serotype O
was  used in 27 articles and most of the analyzed articles
report the use of only one FMDV serotype). In addition, we
were  unable to analyze the interaction terms in the model
with  random effects. But because the two ﬁnal models con-
tain  almost the same variables, we  reported also the results
of  the analysis of the interaction terms of the model with-
out  random effects. Moreover, the model without random
effects including interaction terms had the lowest AIC. Fur-
thermore,  we consider the interaction terms biologically
relevant.
The interaction between “type of secretion and excre-
tion” and “animal species” shows that animal species
inﬂuences the relation between the maximum titres of
FMDV  and the “type of secretion and excretion”, with types
of  secretion and excretion linked to particular species.
For the airborne route, as previous research shows, more
FMDV  is excreted by swine (Donaldson et al., 1970, 1982;
Sellers and Parker, 1969). For other routes, as has been
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entioned, the major secretors and excreters of the virus
re  cattle (Thomson, 1994). The latter has been conﬁrmed
y  our results; our dataset (Fig. 1) shows that URT sec-
etions and excretions from cattle can contain very high
mounts of FMDV (virus titres per ml), in some cases even
igher  than the amounts that are contained in airborne
xcretions from swine (virus titres per day). Considering
hat one of the clinical signs of FMD  in cattle is profuse sali-
ation,  large amounts of saliva with FMDV can be found on
he  ﬂoor of an infected farm, making the contamination of
ifferent  farm appliances (e.g. feedstuff, boots, veterinary
ppliances) feasible and therefore it could be an impor-
ant  vehicle for transmission of the virus between farms.
n  addition, even though milk production drops after infec-
ion  with FMDV, an infected cow still produces 12–16 litres
f  milk per day (Orsel et al., 2007a) meaning that the total
mount of secreted virus with milk is 4 10log higher than
epicted in Fig. 1, much higher than the amount in air-
orne  excretion from swine (Fig. 1). So the concern about
ispersal of FMDV between farms by the bulk tankers is
ealistic  (Thomson, 1994).
Beside  the interaction between “type of secretion and
xcretion” and “animal species” our analysis showed that
lso  the interaction between “type of secretion and excre-
ion”  and “stage of disease” was signiﬁcant. In general, the
mounts  of FMDV are higher in clinically diseased ani-
als  but this is not the case in milk, where it is about the
ame,  with high amounts of FMDV reported in milk samples
hen  clinical signs were not apparent (see Burrows et al.,
968  referring to milk; Hyslop, 1965 referring to saliva).
hile the risk of transmission has been considered (see
harleston et al., 2011) low in the early stage of infection
efore clinical signs are apparent, it has also been shown
hat  the basic reproduction number (the average number
f  new infections cause by a typical infectious individual in
 totally susceptible population) is above 1, meaning that
ajor  outbreaks can still occur in pre-clinical dairy cows
nd  pigs (Orsel et al., 2009). In the study by Charleston
t al. (2011) it was shown that the calves were not infec-
ious  until on average 0.5 days after clinical signs appeared,
ven  though FMDV was detected in secretions and excre-
ions  before the appearance of clinical signs. But, in contrast
o  the study of Orsel, the contact time between calves in
he  Charleston study was limited to only 8 h. This could
xplain why they did not observe transmission between
alves before clinical signs appeared. Further, one should
ealize that FMD  clinical signs are in some cases difﬁcult
o  detect (see Donaldson and Sellers, 2000 on sheep, and
itching and Hughes, 2002 on sheep and goats).
The last two interactions, i.e. between “type of secre-
ion and excretion” and “FMDV serotype” and between
FMDV serotype” and “stage of disease” show that FMDV
erotype inﬂuences both the relation between maximum
itre and type of secretion and excretion and the relation
etween maximum titre and stage of disease. Similar FMDV
erotype-dependent differences have been described for
MDV  elsewhere (Kitching, 2005). Moreover, infection
ith FMDV serotype O may  also lead to higher secretion
nd excretion of the virus during the non-clinical stage of
isease.  However, when adjusting for variability between
xperimental conditions (when using “article” as randomnary Medicine 113 (2014) 23– 33 31
effect),  we  found that FMDV serotype is highly correlated
to  the source of the data. Therefore, conclusions on FMDV
serotype must be taken carefully.
Summarizing, we  show that the total amount of FMDV
secreted and excreted by infected animals depends mainly
on  the maximum titres of FMDV. Secondly, we have identi-
ﬁed  variables related to the maximum amount of secreted
and  excreted FMDV. To relate our ﬁndings with the risk of
transmission of FMDV, future research will need to quantify
the  FMDV-contaminated material transported between
farms and determine the infection rates from this contam-
inated material. The outcome of this analysis shows which
secretion(s) and/or excretion(s) are of major risk for con-
taminating the environment with FMDV. These results can
be  used to prioritize biosecurity measures in contingency
plans.
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